TNF and neoplasm: Additional studies are needed to further define the complexity of this immune response, including assessment of the role of antibody to antigen ratios, the role of TNF and other cytokines, how immune complexes contribute to changes in the phenotype and function of antigen presenting cells over time following in situ immunization with vidutolimod, the specificity of induced cellular immunity and ultimately, on development of a therapeutic anti-tumor response.